Development of a next day functioning measure to assess the impact of sleep disturbance due to restless legs syndrome: The restless legs syndrome-next day impact questionnaire

被引:13
作者
Lasch, Kathryn Eilene [1 ]
Abraham, Lucy [2 ]
Patrick, Jeffrey [3 ]
Piault, Elisabeth Carine [1 ]
Tully, Shannon Elizabeth [1 ]
Treglia, Michael [3 ]
机构
[1] Mapi Values, Boston, MA 02114 USA
[2] Pfizer Ltd, Sandwich CT13 9NJ, Kent, England
[3] Pfizer Inc, New London, CT 06320 USA
关键词
Sleep disorder; Restless legs syndrome; Patient-reported outcomes; Next day function; Quality of life; Questionnaire development; QUALITY-OF-LIFE; RLS EPIDEMIOLOGY; PRIMARY-CARE; PREVALENCE; POPULATION; DEFINITION; VALIDATION; DIAGNOSIS; SYMPTOMS;
D O I
10.1016/j.sleep.2011.03.015
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: Symptoms of Restless Legs Syndrome (RLS) affect patients' quality and duration of sleep, which can have next day sequelae detrimental to daytime performance. To date, no measure sufficiently assesses such sequelae. This study aimed to develop a new self-reported outcome measure to assess the impact of disturbed sleep due to RLS on next day functioning and to support its content validity. Methods: The development of the Restless Legs Syndrome-Next Day Impact (RLS-NDI) questionnaire included concept elicitation interviews with RLS patients in the United States (n = 20); grounded theory data collection and analysis methods; and review by clinical and measurement experts to generate items, responses, and instructions. Cognitive interviews (n = 15) were conducted to ensure understanding of the RLS-NDI, concept comprehensiveness, and identification of any necessary item revisions. Results: Impacts on next day functioning attributed to disturbed sleep due to RLS symptoms included activities of daily living (i.e., work, household chores), cognitive functioning (i.e., concentration, forgetfulness, mental tiredness, alertness), emotional functioning (i.e., irritability, depressed mood), physical functioning (i.e., physical tiredness, active leisure activities), energy, daytime sleepiness, and social functioning (i.e., relationships, social activities/situations). The final measure consists of 14 items assessed "today" and rated on a numeric rating scale. Conclusions: The RLS-NDI is an evaluative tool with demonstrated content validity. (C) 2011 Published by Elsevier B.V.
引用
收藏
页码:754 / 761
页数:8
相关论文
共 50 条
  • [21] Investigation of chronic venous insufficiency in patients with sleep disorders due to restless legs syndrome
    Yolgosteren, Atif
    Leba, Leyla Kose
    Demir, Aylin Bican
    PHLEBOLOGY, 2020, 35 (10) : 771 - 776
  • [22] Restless legs syndrome: Prevalence and impact in children and adolescents - The Peds REST study
    Picchietti, Daniel
    Allen, Richard P.
    Walters, Arthur S.
    Davidson, Julie E.
    Myers, Andrew
    Ferini-Strambi, Luigi
    PEDIATRICS, 2007, 120 (02) : 253 - 266
  • [23] The impact of restless legs syndrome on physical functioning in a community-dwelling population of middle-aged and elderly people
    Hanewinckel, Rens
    Maksimovic, Ana
    Verlinden, Vincent J. A.
    van der Geest, Jos N.
    Hofman, Albert
    van Doorn, Pieter A.
    Boon, Agnita J. W.
    Tiemeier, Henning
    Ikram, M. Arfan
    SLEEP MEDICINE, 2015, 16 (03) : 399 - 405
  • [24] The impact of neuropsychiatric burden on Restless Legs Syndrome (RLS) disease severity
    Kilincarslan, Mehmet Goktug
    Ocak, Ozgul
    Sahin, Erkan Melih
    SLEEP MEDICINE, 2025, 126 : 82 - 87
  • [25] Development and validation of a Subjective Post Sleep Diary (SPSD) to assess sleep status in subjects with Restless Legs Syndrome
    Calloway, Michael
    Bharmal, Murtuza
    Hill-Zabala, Christina
    Allen, Richard
    SLEEP MEDICINE, 2011, 12 (07) : 704 - 710
  • [26] The Impact of Subthalamic Deep Brain Stimulation on Restless Legs Syndrome in Parkinson's Disease
    Dulski, Jaroslaw
    Waz, Piotr
    Konkel, Agnieszka
    Grabowski, Karol
    Libionka, Witold
    Schinwelski, Michal
    Sitek, Emilia J.
    Slawek, Jaroslaw
    NEUROMODULATION, 2021, : 904 - 910
  • [27] Restless legs syndrome in patients with multiple sclerosis: evaluation of risk factors and clinical impact
    Hernandez, L. Lebrato
    Leon, M. Prieto
    Fuentes, N. A. Cerda
    Sanchez, A. J. Ucles
    Chocan, J. L. Casado
    Sanchez, M. Diaz
    NEUROLOGIA, 2022, 37 (02): : 83 - 90
  • [28] Uremic Versus Idiopathic Restless Legs Syndrome: Impact on Aspects Related to Quality of Life
    Gkizlis, Vasileios
    Giannaki, Christoforos D.
    Karatzaferi, Christina
    Hadjigeorgiou, Georgios M.
    Mihas, Costantinos
    Koutedakis, Yiannis
    Stefanidis, Ioannis
    Sakkas, Giorgos K.
    ASAIO JOURNAL, 2012, 58 (06) : 607 - 611
  • [29] The prevalence of the restless legs Syndrome/Willis-Ekbom disease among teenagers, its clinical characteristics and impact on everyday functioning
    Pienczk-Reclawowicz, Karolina
    Pilarska, Ewa
    Olszewska, Anna
    Reclawowicz, Daniel
    Konieczna, Seweryna
    Slawek, Jaroslaw
    SLEEP MEDICINE, 2022, 89 : 48 - 54
  • [30] Comparison of impact of insomnia on depression and quality of life in restless legs syndrome/Willis-Ekbom disease and primary insomnia patients
    Song, Mei Ling
    Oldham, Mark A.
    Park, Kyung Min
    Lee, Eun-Sook
    Lee, Hochang B.
    Cho, Yong Won
    SLEEP MEDICINE, 2015, 16 (11) : 1403 - 1408